ArticleDiabetes2021

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.

Tito Borner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.